Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline + TUDCA in adults with transthyretin amyloidosis
2010-020422-17Phase 2Completed
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of doxycycline and tauroursodeoxycholic acid in transthyretin amyloidosis (ATTR), sponsored by IRCCS San Matteo Foundation. Primary endpoint: Response rate to doxycycline + TUDCA treatment at 12 months. Started Jun 2010; status: completed.
02
Drugs
doxycyclinetauroursodeoxycholic acid
03
Conditions
transthyretin amyloidosis (ATTR)
Beyond the preview
Go deeper on 2010-020422-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020422-17.